A phase I trial of pan-Bcl-2 antagonist obatoclax...

A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer

Chiappori, A A, Schreeder, M T, Moezi, M M, Stephenson, J J, Blakely, J, Salgia, R, Chu, Q S, Ross, H J, Subramaniam, D S, Schnyder, J, Berger, M S
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
106
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2012.21
Date:
February, 2012
File:
PDF, 323 KB
english, 2012
Conversion to is in progress
Conversion to is failed